indirubin-3'-monoxime has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W | 1 |
| Yang, Y | 1 |
| Ying, C | 1 |
| Li, W | 1 |
| Ruan, H | 1 |
| Zhu, X | 1 |
| You, Y | 1 |
| Han, Y | 1 |
| Chen, R | 1 |
| Wang, Y | 1 |
| Li, M | 1 |
1 other study available for indirubin-3'-monoxime and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity.
Topics: Analysis of Variance; Animals; Apoptosis; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Re | 2007 |